Non-Hodgkin lymphoma is a diverse group of diseases. They can range from indolent lymphomas that patients can live with for years without treatment to highly aggressive lymphomas with high 5-year mortality rates. When considering a diagnosis of lymphoma it is important to obtain a core needle or excisional biopsy as fine needle aspiration often leads to inconclusive results and a delay in diagnosis. Risk stratifying patients and initiating treatment when necessary is vital to the initial investigation of a patient with a new diagnosis of lymphoma. Emerging therapies and ongoing clinical trials continue to improve outcomes for this patient population.

Original languageEnglish
Title of host publicationOncology
Number of pages12
ISBN (Electronic)9781119189596
ISBN (Print)9781119189558
StatePublished - 30 Aug 2019


  • Aggressive lymphoma
  • B-cell lymphoma
  • BCR signaling
  • Cutaneous lymphoma
  • Immunochemotherapy
  • Indolent lymphoma
  • Non-Hodgkin lymphoma
  • Radiation
  • T-cell lymphoma


Dive into the research topics of 'Non-hodgkin lymphoma'. Together they form a unique fingerprint.

Cite this